Yüklüyor......
Versatile CAR T-cells for cancer immunotherapy
Chimeric antigen receptor (CAR) T-cell therapy has been clinically proven to efficiently combat haematological malignancies. However, continuous efforts are required to increase the specificity of CAR T-cells against tumour versus normal tissues, and are essential to improve their antitumour activit...
Kaydedildi:
| Yayımlandı: | Contemp Oncol (Pozn) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Termedia Publishing House
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885071/ https://ncbi.nlm.nih.gov/pubmed/29628798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2018.73892 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|